In the search for new drugs, artificial intelligence in the form of diffusion models is being used in drug design. What ...

For R&D leaders evaluating AI investments, I’d offer one piece of advice: Before spending more on models, look hard at your ...

Today, JuliaHub announces the launch of Dyad 3.0 and a $65M series B funding round led by Dorilton Capital, with ...

Materials-to-Royalty Ratio -- 1.5:1 in the quarter, with full-year expectation of 1.3:1 as mix normalizes. Phosphorescent Blue -- Still viewed as a "significant opportunity"; management believes ...

Training AI world models on data about physical environments could improve their real-world capabilities in technologies such ...

But here is the uncomfortable truth that seasoned regulatory professionals already know and that ambitious founders are ...

Toronto Metropolitan University’s Judith Borts examines how the rapid adoption of A.I. is reshaping cybersecurity at every ...

The complexity problem The most direct explanation for why materials misbehave in production is also the most uncomfortable ...

Virtualization is the backbone of modern cloud computing, allowing multiple virtual systems to run on a single physical ...

Recent developments in machine learning techniques have been supported by the continuous increase in availability of high-performance computational resources and data. While large volumes of data are ...

U.S. academic medical centers risk losing leadership in drug discovery and development as global competition—especially from ...

Artificial intelligence (AI) is no longer the stuff of science fiction; it is unleashing a new wave of technological change. In a few short years, the application of AI models has evolved from machine ...